Skip to main content

Tenofovir alafenamide en emtricitabine

J - Antiinfectives For Systemic Use -> J05 - Antivirals For Systemic Use -> J05A - Direct Acting Antivirals -> J05AR - Combinations -> J05AR17 - Tenofovir alafenamide and emtricitabine
Administration category: Free Medicine group: antiviral File parts: emtricitabine tenofovir alafenamide Brand name: Descovy

Standard dosages

≥ 18 years
Weight ROA Load Dosage
ROA:
po
Load:
-
Dosage:
200/10mg 1 dd
ROA:
po
Load:
-
Dosage:
200/25mg 1 dd
Comments:

let op: emtricitabine 200/ tenofoviralafenamide 10 mg bij combinatie met geboost atazanavir, darunavir of lopinavir emtricitabine 200/ tenofoviralafenamide 25 mg bij combinatie met dolutegravir, efavirenz, maraviroc, nevirapine, rilpivirine of raltegravir

Kidney function

≥ 18 years
ROA GFR Dosage Interval Comments
ROA: po
GFR:
10 - 30
Dosage:
do not prescribe
Comments:
gebruik van het combinatiepreparaat wordt ontraden
GFR:
<10
Dosage:
do not prescribe
Comments:
gebruik van het combinatiepreparaat wordt ontraden
Renal elimination: afhankelijk van component

Pregnancy

Due to the expiration of the alphanumeric classification for use in pregnancy and lactation, reference is made to the current, online information of the Teratology Information Service (TIS) of LAREB:

For individual advice, consult an expert on site.
Metadata

Swab vid: M-440589.1
Updated: 06/16/2019 - 20:05
Status: Published

External links
Menu position